文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

347,389+ SCI 论文 与阿拉丁产品引用相关
2,303,681.05 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

产品列表

视图 列表 网格

显示第1429至1440个,产品总数347,389个

切换升序
Science Advances · 2025 ·Vol. 11 ·期 43 · IF 12.5

Label-free robotic mitochondrial biopsy

Yanmei Ma,Weikang Hu,Muyang Ruan,Feixiang Bao,Xingguo Liu,Dong Sun,Hongri Gu,Chengzhi Hu

Robotic micromanipulation has advanced cellular probing, yet achieving precise, minimally invasive intracellular operations without fluorescent labeling remains challenging. Fluorescent techniques often cause photodamage and cytotoxicity and interfere with downstream analyses. Here, we introduce an automated, multifunctional nanoprobing platform capable of label-free extraction of mitochondria from living cells with high spatiotemporal resolution. The nanoprobe integrates two individually addressable nanoelectrodes that perform electrochemical detection of reactive oxygen and nitrogen species, produced by mitochondrial metabolism, followed by dielectrophoretic trapping, manipulation, and extraction of mitochondria. We successfully demonstrated the extraction of mitochondria from living cells, which is validated through fluorescence labeling before and after extraction. Subsequent quantitative polymerase chain reaction further confirmed that the extracted sample contained mitochondria. The fusion of the transplanted mitochondria within the recipient cell’s mitochondrial network confirms their activity. This automated, label-free, in situ organelle extraction micromanipulation system offers a powerful tool for understanding disease mechanisms linked to dysfunctional organelles and enables single-cell surgeries for organelle transplantation.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH · 2025 · IF 1.3

Effects of bergapten-loaded long-circulating liposomes on osteogenic differentiation of human dental pulp stem cells

Hao-Nan Ding,Xu-Wen Wang,Yu-Xin Qian,Ke Liu,Lei Jin

Bergapten is a natural compound with the potential to regenerate bone. However, its poor solubility and instability hinder its clinical use. We developed bergapten-loaded long-circulating liposomes (BP-LCL) to overcome these challenges. The liposomes were spherical, stable, and highly effective at delivering bergapten. We found that BP-LCL were biocompatible and enhanced the osteogenic differentiation of human dental pulp stem cells. It did this by increasing key markers like RUNX2, COL1, and OCN, and by activating the Wnt/β-catenin signaling pathway. This study suggested that BP-LCL could be a promising new approach for bone regeneration settings.

CAS / MDL: 484-20-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Frontiers in Bioengineering and Biotechnology · 2025 · IF 4.8

Application of BMSCs-coated PLGA/type I collagen composite mesh in intraperitoneal onlay mesh repair using a rat ventral incisional hernia model

Mingliang He,Yi Pan,Jiayi Li,Yaqin Qi,Kangbei Zhu,Fangjie Zhang

Purpose This study aimed to address the limitations of synthetic meshes in incisional hernia repair by developing a bioactive composite mesh combining poly(lactic-co-glycolic acid) (PLGA), type I collagen, and bone marrow mesenchymal stem cells (BMSCs). Methods The PLGA scaffolds, fabricated via freeze-drying, were modified with collagen to enhance biocompatibility and loaded with BMSCs to promote tissue regeneration. In vitro and in vivo evaluations in a rat ventral hernia model assessed biomechanical properties, anti-adhesion efficacy, and tissue integration. Results The PLGA-Collagen I-BMSCs mesh exhibited superior anti-adhesion performance, reduced inflammatory cell infiltration by 73.3%, and enhanced neovascularization compared to commercial meshes (Sepramesh™ and Parietex™). BMSCs modulated TGF-β1/Smad3 signaling to mitigate fibrosis, while collagen alignment improved mechanical recovery. The composite mesh degraded at a rate matching tissue regeneration, with 10% PLGA maintaining structural integrity for 20 weeks. Histological analysis revealed organized collagen deposition and minimal adhesions (Nair grade 0–1 in 100% of cases). Conclusion These findings highlight the potential of the PLGA-Collagen I-BMSCs composite as an innovative intraperitoneal onlay mesh (IPOM) solution, offering mechanical stability, anti-adhesive properties, and regenerative bioactivity. This strategy shifts hernia repair from passive support to active tissue regeneration, providing a foundation for next-generation hernia repair materials.

CAS / MDL: 123-91-1
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Stem Cells International · 2025 ·Vol. 2025 ·期 1 ·5243270 · IF 3.3

Therapeutic Potential of hucMSC-EVs in Diabetic Kidney Disease via Regulating the miR-146b-5p/Merlin/YAP Axis

Bei Li,Qiongni Wang,Linru Shi,Qifeng Liu,Hui Qian,Lixia Yu,Cheng Ji

Diabetic kidney disease (DKD) is characterized by a continuous decline in renal function and progressive fibrosis, making it a leading cause of end-stage kidney disease with limited therapeutic options. Recently, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown great potential in tissue regeneration and repair, offering a new avenue for the treatment of DKD. The purpose of this study is to explore the function and mechanism of action of EVs derived from human umbilical cord MSCs (hucMSC-EVs) in the development of DKD. Our findings show that under high-glucose (HG) conditions, miR-146b-5p is highly expressed in glomerular mesangial cells, downregulating the target protein Merlin, which promotes the activation of the YAP signaling pathway and induces mesangial cell fibrotic-like changes, leading to a significant deposition of collagen and interstitial fibrosis in the kidney. In vivo and in vitro experimental findings reveal that hucMSC-EVs can significantly inhibit miR-146b-5p, upregulate Merlin expression, prevent the nuclear translocation of YAP, improve renal function, and reduce collagen deposition, demonstrating a significant antifibrotic effect. The findings of this study emphasize the central role of the miR-146b-5p/Merlin/YAP axis in hucMSC-EVs-mediated inhibition of renal fibrosis and highlight the potential of MSC-EVs as a targeted nanotherapeutic strategy for DKD.

CAS / MDL: 69-65-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
INTERNATIONAL IMMUNOPHARMACOLOGY · 2025 · IF 4.7

SHP2 Allosteric Inhibitor SHP099 Alleviates Inflammation and Restores Salivary Gland Function in Sjögren's Disease-like Animals via Regulation of the IL-17RA Signaling Pathway

Simin Wang,Xiuhong Weng,Chang Liu,Bo Cheng

Salivary gland (SG) dysfunction is a hallmark manifestation of Sjögren's disease (SjD). While SHP2 has been implicated in several autoimmune diseases, its specific function in SjD remains to be elucidated. Here, we investigated the involvement of SHP2 in SjD-induced SG damage and elucidate the underlying molecular mechanisms. Our findings revealed that SHP2 is elevated in SG tissues of SjD patients and SjD-like animals, with predominant localization to salivary gland epithelial cells (SGECs) of acini and ducts. Notably, pharmacological inhibition of SHP2 with the allosteric inhibitor SHP099 significantly alleviates SG histopathological damage and reduces inflammatory cell infiltration in SjD-like animals. In vitro studies in the human SGEC line A253 revealed that SHP2 inhibition attenuated poly(I:C)-induced SGEC apoptosis and proinflammatory cytokine production. Mechanistically, SHP099 treatment disrupted the IL-17RA/ACT1/TRAF6 signaling axis, phenocopying the effects of SHP2 knockdown and direct IL-17R antagonism, which leads to downregulation of JAK/STAT3 and NF-κB pathways. Collectively, our findings highlight the significant involvement of SHP2 in the pathogenesis of SjD and suggest that targeting SHP2 or its downstream signaling pathways may represent a promising therapeutic approach for SjD treatment.

✓ 已验证 DOI PubMed 高影响因子
查看原文 查看 PubMed
Autophagy · 2025 · IF 14.3

Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity

Zizheng Gao,Jiaqi Zhang,Huangxi Fu,Shaoyin Zhang,Jian Chen,Haiyang Zhou,Xueqin Chen,Xiaochen Zhang,Hao Yan,Bo Yang,Qiaojun He,Zhifei Xu,Peihua Luo

Entrectinib stands unparalleled as the sole neurotrophic tyrosine receptor kinase (NTRK) inhibitor that has demonstrated clinical efficacy in treating brain metastases across various cancer types. However, its potential to induce severe cardiotoxicity, compounded by the current lack of effective intervention strategies, poses a substantial risk of treatment failure, underscoring the critical need for in-depth research on the molecular mechanism. Here, we utilized proteomics analysis and a murine model with cardiomyocyte-specific atg7 deletion to reveal that entrectinib activated autophagy in cardiomyocytes, subsequently triggering apoptosis and leading to cardiac dysfunction. Mechanistically, entrectinib directly bound to the HMGB1 protein at the 103rd phenylalanine residue, enhancing its nuclear localization. In the nucleus, HMGB1 suppressed the transcription of the deubiquitinating enzyme OTUD5, a vital regulator of the MTORC1 pathway, which subsequently inhibited the MTORC1 pathway, culminating in the activation of macroautophagy/autophagy. Furthermore, our research demonstrated that HMGB1 inhibition could prevent the cardiotoxicity induced by entrectinib in both in vivo and in vitro models. Specifically, we found that tanshinone IIA could mitigate the cardiotoxic effects of entrectinib by reducing HMGB1 protein levels. Taken together, our findings elucidated the mechanism underlying entrectinib-induced cardiotoxicity, offering a theoretical foundation for the safer clinical application of this targeted therapy.Abbreviations and Acronyms: ATG7: autophagy related 7; CHX: cycloheximide; CKMB: creatine kinase myocardial band; CQ: chloroquine; c-PARP: cleaved poly (ADP-ribose) polymerase family; DAPI: 4‘6-diamidino-2-phenylindole; EF: ejection fraction; FS: fractional shortening; GSEA: gene set enrichment analysis; H&E: hematoxylin and eosin; HW:TL: ratio of heart weight to tibia length; KEGG: Kyoto Encyclopedia of Genes and Genomes; MYH6: myosin heavy polypeptide 6, cardiac muscle, alpha; MYH7: myosin, heavy polypeptide 7, cardiac muscle, beta; NPPA: natriuretic peptide type A; NPPB: natriuretic peptide type B; PI: propidium iodide; qPCR: quantitative real-time PCR; SD: standard deviation; SRB: sulforhodamine B; WGA: wheat germ agglutinin.

CAS / MDL: 128446-35-5
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
DRUG DELIVERY · 2025 · IF 8.1

Oral nanoliposomes functionalized with cRGD and polydopamine for enhanced antimalarial efficacy of disulfide bond-modified dihydroartemisinin prodrug

Liqing Chai,Xiaomin Niu,Xiaoning Li,Jingjing Han,Fugui Guo,Rongrong Wang,Xiaohui Zhou,Xiaozhou Dong,Guoshun Zhang,Ruili Wang,Guolian Ren

Malaria remains a global health crisis, with Plasmodium resistance underscoring the urgent need for advanced drug delivery strategies. To overcome the limitations of oral antimalarials, such as hepatic first-pass metabolism and insufficient drug accumulation in parasites, intestinal M cell-mediated lymphatic transport and Plasmodium-triggered drug release are effective strategies. Plasmodium parasites maintain a weakly acidic intracellular environment with high levels of glutathione (GSH). Polydopamine (PDA) remains stable in the gastrointestinal tract and degrades in the parasite’s weakly acidic, GSH-rich environment, making PDA nanoliposomes (PNLs) a promising oral delivery system for Plasmodium-responsive drug release. Additionally, cyclic arginine–glycine–aspartic acid (cRGD) can specifically target intestinal M cells, promoting lymphatic transport and thereby reducing the first-pass effect. We developed cRGD- and PDA-modified nanoliposomes (cRPNLs) to address the challenges associated with oral administration and loaded them with a disulfide bond (–SS–)-modified dihydroartemisinin (DHA) prodrug (DSSC) to simultaneously deplete GSH and induce lethal oxidative stress, thereby offering an enhanced antimalarial mechanism. In vitro, cRPNLs exhibited pH- and GSH-responsive DHA release. Ex vivo fluorescent imaging confirmed that cRPNLs targeted Peyer’s patches with minimal distribution in the liver. Crucially, both PNLs and cRPNLs reduced GSH levels in infected erythrocytes and elevated ROS by 2.0-fold, outperforming unmodified DHA. Pharmacokinetic and in vivo antimalarial pharmacodynamic studies revealed that cRPNLs exhibited significantly higher exposure and Plasmodium inhibition rates compared to PNLs and free DHA. These results highlight cRPNLs as a potent oral nanoplatform that combines M cell-mediated lymphatic uptake with parasite-triggered drug release, significantly improving antimalarial efficacy.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Frontiers in Immunology · 2025 · IF 5.9

Selenium nanoparticle-delivered MDM2 inhibitor reactivates p53 and reprograms tumor immune microenvironment in colorectal cancer

Weiming You,Jun Feng,Litao Guo,Jin Yan,Siqi Yan

Background Colorectal cancer (CRC) remains a major global health challenge, with limited immunotherapy efficacy in microsatellite stable (MSS) tumors that comprise ~85% of cases. The p53 tumor suppressor pathway, frequently inactivated through the mouse double minute 2 homolog (MDM2) overexpression in wild-type tumor protein 53(TP53) tumors, represents a promising therapeutic target for both direct antitumor effects and immune modulation. Methods We developed selenium nanoparticles loaded with the MDM2-targeting peptide inhibitor MI (Se@MI) using a one-pot synthesis approach. The nanoparticles were characterized by transmission electron microscopy, dynamic light scattering, and UV-Vis spectroscopy. In vitro assays included MTT cytotoxicity evaluation, cellular uptake by flow cytometry, RNA-seq, and Western blotting of p53-pathway/apoptosis markers. Antitumor efficacy was evaluated in CT26 murine colorectal cancer models, with mechanistic studies including transcriptomic analysis, immunohistochemistry, and flow cytometry. Safety profiles were assessed through body weight monitoring, hematological analysis, histopathological examination of major organs, and serum biomarker evaluation. Results Se@MI nanoparticles demonstrated uniform spherical morphology (45-50nm diameter) and displayed a positive zeta potential (+24.69 mV), indicative of favorable colloidal dispersibility. Enhanced cellular uptake (74.3% positive cells) and potent cytotoxicity (IC 50 = 1.00 μM) were observed in CT26 cells. Transcriptomic analysis revealed significant activation of p53 signaling pathways (NES = 1.504, P = 0.029) and protein analyses confirmed induction of p21, PUMA, Bax, and cleaved caspase-3. In vivo , Se@MI treatment achieved 72.23% tumor growth inhibition, significantly outperforming controls. Mechanistically, Se@MI restored p53 function by disrupting MDM2-p53 interactions, inducing apoptosis and cell cycle arrest. Importantly, Se@MI reprogrammed the tumor immune milieu through increased infiltration of CD8+ T cell and cytotoxic function while suppressing regulatory T cells. Comprehensive safety evaluation revealed excellent biocompatibility with no adverse effects on body weight, hematological parameters, organ histology, inflammatory cytokines, or hepatic/renal function markers. Conclusions Se@MI represents a novel nanomedicine strategy that combines direct p53 pathway reactivation with immune microenvironment modulation. This dual mechanism of action offers a potential strategy to boost immunotherapeutic outcomes in colorectal carcinoma and may help overcome resistance mechanisms to immune checkpoint blockade.

CAS / MDL: 7783-00-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
ELECTROPHORESIS · 2025 ·Vol. 46 ·期 21 ·1576-1587 · IF 2.5

Study on Dissociated States of Monocarboxylic Acids and Their Interactions With MCT1 by Capillary Electrophoresis With Interface-Induced Current Detector

Tao Huang,Chunsu Liang,Xiaomei Ling

High-performance capillary electrophoresis (CE) has been widely applied in the analysis of organic acids, especially monocarboxylic acids (MAs), but no studies on the CE analysis of dissociated states of MAs have been reported. Here, 15 MAs were analyzed by the newly developed universal interface-induced current detector (IICRD). Two current signal peaks were observed in current electrophoretograms (CR-EGs), whereas only one peak with low sensitivity can be obtained by diode array detector (DAD). The current signal peaks of MAs were accurately identified by adding a charge-neutral marker and calculating by p K a . The qualitative analysis indicated that the two current signal peaks of MAs were charge-neutral forms [MA ± ] and monovalent anions [MA − ] in order. Quantitative analysis showed that CE-IICRD can enhance the sensitivity of MA analytes to 40 µM in limit of detection (LOD), with a linear range from 10 −6 to 10 −2 M. Furthermore, interactions between different dissociated states of MAs and monocarboxylate transporter 1 (MCT1) were studied by combined application of nonimmobilized cell CE (NICCE) method for the first time. The binding kinetic parameters and mole number of MCT1 on cell membranes can also be obtained. Besides, competitive binding experiments proved that BAY-8002 (MCT1-specific inhibitor) and lactic acid shared the same binding site. CE-IICRD provides a new method to reveal the interaction between different dissociated forms of MAs or other biomolecules and essential receptors.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
LUMINESCENCE · 2025 ·Vol. 40 ·期 11 ·e70328 · IF 3

Smartphone-Integrated Ratiometric Fluorescent Sensing Platform Based on Carbon Dots for One-Step Detection of Glyphosate

Tingting Lei,Yating Xu,Siyi Tan,Jiafu Xiao,Shaojing Zhao,Minhuan Lan

An ability to effectively detect glyphosate residues in food and the environment on-site remains a challenge. Herein, we developed a ratiometric fluorescent sensing platform based on blue fluorescent carbon dots (B-CDs) and red carbon dots (R-CDs) for rapid, visual, and quantitative detection of glyphosate. Although B-CDs, which were functionalized with abundant amino and hydroxyl groups, caused glyphosate-mediated aggregation-caused quenching (ACQ) via hydrogen bonding effect, R-CDs acted as a stable internal reference. The system could detect glyphosate in one step within 20 s and had a low detection limit of 2.87 μM. During the detection process, the fluorescent color changes from blue to red. On-site detection can be achieved by using the RGB analysis integrated in the smartphone. The sensor had high selectivity to glyphosate, despite the presence of metal ions, biomolecules, and various pesticides. It was successfully applied to detect actual water samples with recovery rates of 81.8%–96.6% (RSD ≤ 11.1%). With its rapid response, smartphone compatibility, and robustness in detecting complex matrices, the proposed sensor has promising potential for the monitoring of glyphosate in agricultural and environmental samples.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF SEPARATION SCIENCE · 2025 ·Vol. 48 ·期 10 ·e70298 · IF 2.8

Direct Determination of Glucosamine and Its Isomers in Pharmaceutical Formulations by Capillary Electrophoresis With Amperometric Detection

Dingxuan Li,Jiayue Liu,Ruotong Zheng,Qingcui Chu

The studies have shown that glucosamine (GluN) and mannosamine (ManN) are important nutrients for the formation of chondrocytes, while galactosamine (GalN) is a hepatotoxin with high selectivity. Therefore, the separation and detection of aminosaccharide isomers are of critical significance for pharmaceutical quality monitoring. In this work, a novel method was established for the separation and direct determination of GluN and its isomers (GalN and ManN) based on capillary electrophoresis with amperometric detection. The critical factors affecting electrophoretic separation and electrochemical detection were investigated in detail. Under the optimum conditions, three aminosaccharide isomers and their precursor monosaccharides (glucose, galactose, and mannose) can achieve baseline separation. The limits of detection reached 0.070–0.23 µg/mL (S/N = 3), showing good linearity within two orders of magnitude ( R 2 > 0.99), and the recovery data were in the range of 96.0%-107.8%. This developed method has been applied for the analysis of aminosaccharide pharmaceuticals in different dosage forms. This proposed method is simple to operate, requires no derivatization, and is environmentally friendly, providing an alternative method for the direct determination of aminosaccharides in pharmaceutical formulations. Furthermore, the greenness and eco-friendliness of this developed method were assessed by the green analytical procedure index, analytical greenness, and analytical eco-scale tools.

✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
Research · 2025 · IF 10.7

Enhanced Microwave Trapping and Loss Capabilities of TiN/RGO/PDMS Metacomposites across a Wide Range of Temperatures

Haoxu Si,Shuai Zhang,Yaqin Ding,Chongyang Chai,Shuaishuai Zhou,Cuiping Li,Jingwei Zhang,Chunhong Gong

According to the relationship between unit size and wavelength, electromagnetic waves (EMWs) in metacomposites can be effectively absorbed through inherent loss mechanisms. However, limited loss ability has emerged as a primary obstacle to achieving efficient EMW absorption (EMWA) performance. The challenge of enhancing the attenuation of corresponding metacomposites remains important. In this study, we prepared elaborate titanium nitride/reduced graphene oxide units with controllable conductivities and sizes, which formed the microwave antireflective surface of metacomposites. This configuration contributes to improved impedance matching and reduced temperature sensitivity concerning EMWA performance. More importantly, EMWs experience repeated collisions and loss, along with multiple reflections and scattering within metacomposites. This phenomenon extends the transmission pathways of EMWs, thereby increasing additional loss capacity. Consequently, these metacomposites exhibited exceptional EMWA performance across a broad temperature range (298 to 573 K), while maintaining a low filler content of 1.0 wt% units. Henceforth, our findings not only provide an advantageous pathway for high design flexibility in EMWA but also pave the way for new research directions and possibilities regarding advanced lightweight metacomposites that optimize EMWA over an extensive temperature range.

CAS / MDL: 7585-20-8
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。